HEPARIN-INDUCED THROMBOCYTOPENIA AND HEART OPERATION - MANAGEMENT WITH TEDELPARIN

被引：19

作者：

ALTES, A

MARTINO, R

GARI, M

CAMARA, ML

GARIN, R

CASAS, JI

FONTCUBERTA, J

机构：

[1] HOSP SANTA CRUZ & SAN PABLO,DEPT HEMATOL,SERV CIRURG CARDIACA,UNITAT HEMOSTASIA & TROMBOSI,E-08025 BARCELONA,SPAIN

[2] HOSP SANTA CRUZ & SAN PABLO,DEPT HEMATOL,SERV ANESTESIA & REANIMACIO,E-08025 BARCELONA,SPAIN

来源：

ANNALS OF THORACIC SURGERY | 1995年 / 59卷 / 02期

关键词：

D O I：

10.1016/0003-4975(94)00572-O

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Anticoagulation for cardiopulmonary bypass in the infrequent clinical setting of thrombocytopenia associated with the use of unfractionated heparin is a very serious problem. We describe a case in which a low-molecular-weight heparin (tedelparin) was selected for this purpose based on a platelet aggregation test, permitting adequate anticoagulation during cardiopulmonary bypass for valve replacement. This case report might help establish an adequate anticoagulation protocol when faced with a patient suffering from this condition.

引用

页码：508 / 509

页数：2

共 7 条

[1]

BRATT G, 1990, THROMB HAEMOSTASIS, V64, P506

[2]

CHONG BH, 1993, THROMB HAEMOSTASIS, V69, P344

[3]

CHONG BH, 1989, BLOOD, V73, P1592

[4]

MAGNANI HN, 1993, THROMB HAEMOSTASIS, V70, P554

[5]

MASSONNETCASTEL S, 1986, HAEMOSTASIS, V16, P139

[6]

ROBITAILLE D, 1992, J THORAC CARDIOV SUR, V103, P597

[7] ANCROD ANTICOAGULATION FOR CARDIOPULMONARY BYPASS IN HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS [J].

TEASDALE, SJ ;

ZULYS, VJ ;

MYCYK, T ;

BAIRD, RJ ;

GLYNN, MFX .

ANNALS OF THORACIC SURGERY, 1989, 48 (05) :712-713

← 1 →